/**
 * Seed a second batch of editorial blog posts (money-keyword topics).
 * Idempotent: ON CONFLICT (slug) DO UPDATE.
 *
 * Run: node --env-file=.env.local --import tsx scripts/seed-blog-batch2.ts
 */

import postgres from "postgres";

const POSTS = [
  {
    slug: "knee-replacement-cost-india-vs-thailand-vs-turkey",
    title: "Knee replacement cost: India vs Thailand vs Turkey, honestly compared",
    category: "Cost comparisons",
    excerpt:
      "Same implant, same technique, wildly different prices. But the top-line cost is only the first filter. Here's how the three big destinations actually differ on implant tier, surgeon volume, and post-op physiotherapy.",
    authorName: "MedCasts Editorial · Reviewed by Dr. A. Gupta, MS Orthopedics",
    publishedAt: "2026-03-30T09:00:00Z",
    content: `
<p>On paper, a total knee replacement runs $4,500–$7,000 in India, $11,000–$15,000 in Thailand, and $8,000–$13,000 in Turkey. Those are the numbers we see on actual quotes we process for international patients, not the marketing copy. The cost gap is real. The question is what drives it, and whether the cheaper option is actually cheaper once you factor everything in.</p>

<h2>What's actually in the quote</h2>
<p>The biggest quote variance is <em>not</em> the surgical fee — it's the implant. A tier-1 implant (Zimmer Persona, Stryker Triathlon, DePuy Attune) adds $1,500–$3,000 to the base quote. A lower-tier or gray-market implant can look identical on paper but behave differently at year 10. Ask in writing: which implant brand, which size, and is the packaging tier-1 or value tier.</p>

<p>Physiotherapy is the second big variable. Indian quotes often include 5–7 days of inpatient physio; Thai quotes sometimes include residential rehab for 2–3 weeks; Turkish quotes typically bundle a minimal physio package and expect you to arrange outpatient sessions locally. If you're flying home soon, Thai packages look expensive but save you two months of post-op work.</p>

<h2>Surgeon volume reality check</h2>
<p>India runs the highest total-knee volumes globally — the top orthopedic centers in Delhi, Mumbai, and Chennai each do 2,000–4,000 joint replacements a year. Thailand runs lower volumes but deeper international-desk polish. Turkey is the fastest-growing market and volumes vary enormously between centers — it's the destination where asking for surgeon-specific volume matters most.</p>

<h2>Our rule of thumb</h2>
<p>If the procedure is straightforward (primary TKR, healthy patient, no prior surgery), India on a tier-1 implant is our most common recommendation — best volume, best cost. If it's a revision, complex deformity, or bilateral, Germany becomes worth the extra cost. Turkey is a fair middle path for European patients on flight-distance alone.</p>

<p>Whatever you pick, insist on two things before booking: implant brand in writing, and a physiotherapy plan that covers the first 6 weeks post-op. Those are the two line items that most often get swapped silently between quote and surgery.</p>
    `.trim(),
  },

  {
    slug: "hair-transplant-turkey-hidden-costs",
    title: "Hair transplant in Turkey: what the $1,500 package leaves out",
    category: "Cost comparisons",
    excerpt:
      "Yes, Istanbul runs the world's largest hair-transplant market, and yes, prices are remarkable. But the all-inclusive package hides several line items that matter. Here's our read on what to ask before you book.",
    authorName: "MedCasts Editorial · Reviewed by Dr. M. Ozdemir, Dermatologic Surgery",
    publishedAt: "2026-04-02T09:00:00Z",
    content: `
<p>We refer a lot of hair-transplant patients to Turkey. The pricing is genuinely competitive — $1,500–$3,000 for 3,000–4,000 grafts is the normal band, and that's running on modern DHI and sapphire-FUE technique in well-equipped clinics. It's also the most over-marketed medical-travel category on the internet, which makes honest information hard to find.</p>

<h2>What "all-inclusive" usually includes</h2>
<p>Standard package: extraction + implantation, airport pickup, hotel (usually 2–3 nights), interpreter, post-op shampoo kit, 1 follow-up consultation. That's a legitimate package and it's what the price reflects.</p>

<h2>What it often doesn't include — and matters</h2>
<ul>
  <li><strong>Who actually does the work.</strong> In many high-volume Turkish clinics, the surgeon does the incisions and planning; technicians do the extraction and implantation. This isn't necessarily bad — experienced technicians consistently produce good results — but it's rarely disclosed. Ask: who is doing which step, and what are their individual case counts.</li>
  <li><strong>Graft count vs yield.</strong> "4,000 grafts" can mean 4,000 follicular units or 4,000 <em>hairs</em> (each unit has 1–4 hairs). The difference is 30–50%. Get the number in follicular units.</li>
  <li><strong>Density planned.</strong> A reasonable target is 40–50 grafts per square cm in the frontal hairline. Some high-volume clinics run 25–30 to stretch graft counts. You won't notice for 6 months; you'll notice at year 2.</li>
  <li><strong>PRP and aftercare products.</strong> Often billed separately. A standard add-on is 2–3 PRP sessions for $150–$400 each; the first is sometimes folded in.</li>
  <li><strong>Revision policy.</strong> If density under-delivers at 12 months, what's the clinic's obligation? Get this in writing <em>before</em> the procedure, in English.</li>
</ul>

<h2>Turkey vs alternatives</h2>
<p>For pure cost-volume, Turkey is still the answer. For more conservative standards of care — slower, smaller sessions, surgeon doing the full procedure — South Korea, Thailand, and parts of India are worth comparing. The cost gap closes to maybe $1,500 once you factor that in, and for some patients the extra standardization is worth it.</p>

<p>The shortcut: pick by the specific surgeon's verified before-and-after photos (not generic clinic galleries), confirm technician-vs-surgeon split in writing, and get the graft count in follicular units. If the clinic is cagey on any of those three, keep shopping.</p>
    `.trim(),
  },

  {
    slug: "ivf-success-rates-how-to-read",
    title: "IVF success rates: how to read them (and what clinics don't publish)",
    category: "Fertility",
    excerpt:
      "Published IVF success rates are the most gamed metric in medical travel. Here's how to separate a real live-birth rate from marketing, and the specific questions that separate a serious clinic from an aggressive one.",
    authorName: "MedCasts Editorial · Reviewed by Dr. L. Fernandez, Reproductive Endocrinology",
    publishedAt: "2026-04-06T09:00:00Z",
    content: `
<p>IVF clinics publish success rates differently. "70% success rate" on a clinic's homepage can mean any of four things, and three of them don't match what you actually care about — bringing a baby home.</p>

<h2>The four numbers, ranked by how useful they are</h2>
<ol>
  <li><strong>Live-birth rate per cycle started.</strong> This is the number that matters. It counts everyone who started stimulation, not just who made it to transfer. It's also the lowest number.</li>
  <li><strong>Live-birth rate per transfer.</strong> Second best. Counts people who got to transfer but excludes those whose cycle was cancelled before that.</li>
  <li><strong>Clinical pregnancy rate per transfer.</strong> A heartbeat on ultrasound at 6–8 weeks. This misses miscarriages after that point, which are common.</li>
  <li><strong>Positive beta-hCG.</strong> A pregnancy test turned positive. Includes early losses, ectopics, and biochemicals. This is the most-inflated number and also the one clinics quote most often.</li>
</ol>

<p>If a clinic publishes anything other than #1 or #2, push for the real live-birth data. A serious clinic will give it to you stratified by age bracket. An aggressive one will deflect.</p>

<h2>The age stratification you need</h2>
<p>IVF success is heavily age-dependent. A blended number across all ages is close to useless. You want: under 35, 35–37, 38–40, 41–42, over 42. The difference between 32 and 42 is roughly a factor of 3–4× in live-birth rate, so a clinic that looks good on a blended number may actually be median-at-best for your age.</p>

<h2>Specific questions we send to clinics before we refer</h2>
<ul>
  <li>Live-birth rate per cycle started, last 12 months, stratified by 5-year age bracket.</li>
  <li>Average number of embryos transferred per cycle (elective single-embryo transfer is the modern standard; 2+ is older practice and raises twin risk).</li>
  <li>Preimplantation genetic testing (PGT-A) rate — what percentage of cycles get it, and is it included or billed separately.</li>
  <li>Cancellation rate (cycles started but not reaching retrieval).</li>
</ul>

<h2>Where to go</h2>
<p>Spain and Greece are the strongest regulated markets for donor-egg cycles. India has cost-leading rates for straight IVF. Kazakhstan, Georgia, and Mexico handle most current international surrogacy volume. Wherever you go, get a family-law review in your home jurisdiction before booking any donor or surrogacy arrangement — that's where cross-border fertility cases most often fall over.</p>
    `.trim(),
  },

  {
    slug: "second-opinion-oncology-abroad",
    title: "When to get a second oncology opinion abroad (and when not to)",
    category: "Second opinions",
    excerpt:
      "A second opinion changes the treatment recommendation in about 28% of the oncology cases we send abroad. But there are also cases where it won't help. Here's the pattern we see.",
    authorName: "MedCasts Editorial · Reviewed by Dr. P. Srinivasan, MD Medical Oncology",
    publishedAt: "2026-04-09T09:00:00Z",
    content: `
<p>We track outcomes on the second oncology opinions we route. Across roughly 180 cases last year, 28% came back with a <em>materially different</em> treatment recommendation — a different drug combination, a different sequencing of surgery and systemic therapy, or in a handful of cases, a recommendation against an operation that had already been scheduled. That's higher than most patients expect.</p>

<p>But it's not universal. There are cases where a second opinion usually confirms what you already have, and burning 2 weeks on it delays care that's time-sensitive. Here's how we triage.</p>

<h2>Cases where a second opinion is almost always worth it</h2>
<ul>
  <li>Rare tumor types (sarcoma, neuroendocrine, rare head-and-neck subtypes) — expertise is concentrated in a small number of centers worldwide.</li>
  <li>Any recommendation for extensive/mutilating surgery — breast conservation vs mastectomy, limb-sparing vs amputation, bowel resection scope.</li>
  <li>Borderline operable vs inoperable staging calls — these are judgment calls where experienced multidisciplinary centers often see the picture differently.</li>
  <li>Cases where no molecular/genomic profiling has been done — targetable mutations change the whole plan.</li>
  <li>Second-line and beyond — the evidence base is thinner and variation in practice is wider.</li>
</ul>

<h2>Cases where a second opinion rarely changes much</h2>
<ul>
  <li>Early-stage, surgically straightforward disease with a clear standard-of-care pathway.</li>
  <li>Cases where timing is critical (acute hematologic malignancies, rapidly-progressing solid tumors) — delays to travel or to coordinate a second opinion may cost more than the upside.</li>
  <li>Cases where the originating center is already a high-volume academic cancer center with a documented tumor board.</li>
</ul>

<h2>How to actually get one</h2>
<p>You need three things: your imaging on CD or via DICOM share, your pathology block (or a slide review the new center can trust), and a summary letter from your current oncologist. Good international programs will give you a written opinion within 5–10 working days; the turnaround is longer than you'd guess because pathology re-reads take time and are the hardest part to rush.</p>

<p>We coordinate second oncology opinions free of charge across our partner programs in Germany, India, Singapore, and the US. If you're in the window where a second opinion might change the plan, it's worth the two weeks.</p>
    `.trim(),
  },

  {
    slug: "bariatric-surgery-turkey-what-to-ask",
    title: "Bariatric surgery in Turkey: the five questions that filter a good program from a cheap one",
    category: "Bariatric",
    excerpt:
      "Turkey dominates the international bariatric market on volume and cost. The best programs are genuinely world-class. The worst cut corners in ways you won't feel until month six. These five questions separate them.",
    authorName: "MedCasts Editorial · Reviewed by Dr. E. Demir, MD Bariatric Surgery",
    publishedAt: "2026-04-12T09:00:00Z",
    content: `
<p>Bariatric surgery is one of the fastest-growing medical-travel categories, and Turkey is the dominant destination — probably 60–70% of international bariatric volume on our desk. The top centers in Istanbul, Izmir, and Antalya run genuinely world-class programs with high volumes, modern staplers, and strong multidisciplinary teams. The bottom end of the market is cheap for a reason.</p>

<p>Here are the five questions we send to any Turkish bariatric program before we'll forward a quote.</p>

<h2>1. Who performs the surgery, and what's their personal annual volume?</h2>
<p>Bariatric surgery is volume-sensitive. A surgeon doing 200+ sleeves a year has meaningfully different outcomes from one doing 30. Hospital-wide volumes are less useful — ask about the individual surgeon.</p>

<h2>2. What's the pre-op workup protocol?</h2>
<p>A good program requires: BMI qualification check, nutritional assessment, psychiatric screening for eating disorders, and appropriate cardiac/pulmonary workup for older or comorbid patients. A program that can surgery-ready you in 3 days from first contact is cutting one or more of those corners.</p>

<h2>3. Stapler brand, and is it included in the quote?</h2>
<p>Ethicon and Medtronic are the two main tier-1 stapler manufacturers. Generic staplers exist and are cheaper; they also have higher reported leak rates. Ask specifically, get it in writing, and confirm whether the price changes if a tier-1 stapler is requested.</p>

<h2>4. Leak test protocol and what happens if there's a complication</h2>
<p>Intraoperative leak tests (methylene blue or air) and early post-op imaging (gastrografin on day 2–3) catch leaks before they become abscesses. Ask about both. Also ask: if you have a complication after flying home, what's the pathway? A real program has one documented.</p>

<h2>5. Nutritional and psychological follow-up for the first 12 months</h2>
<p>Months 6–18 are where most bariatric patients run into trouble — nutritional deficiencies, hair loss, dumping, weight regain starting at 18 months. A program that can only follow you by email while you're offshore is not offering you real follow-up. Ask what telemedicine schedule is included, what labs they monitor, and how the dietitian is reachable.</p>

<h2>The red flags</h2>
<p>Any program that: quotes you without a BMI check, offers "surgery next week" from first contact, won't name the stapler brand, or prices revisions as aggressively as primary surgery. Cost $3,500–$5,500 for a sleeve in Turkey is normal. Cost below $3,000 with airport transfers and hotel bundled is almost always cutting a corner that matters in year two.</p>
    `.trim(),
  },

  {
    slug: "germany-vs-india-complex-surgery",
    title: "Germany vs India for complex surgery: when the price gap is worth paying",
    category: "Destinations",
    excerpt:
      "Germany is typically 5–8× the cost of India for complex surgery. Sometimes that's the right call. More often it isn't. Here's the pattern we've seen across 400+ complex referrals.",
    authorName: "MedCasts Editorial · Reviewed by Dr. H. Weiss, FRCS",
    publishedAt: "2026-04-15T09:00:00Z",
    content: `
<p>We route roughly 4:1 toward India vs Germany for complex international surgery. That's not a recommendation; it's a cost reality. But we also route some patients the other way — and the pattern of which ones is worth explaining.</p>

<h2>When India is our first recommendation</h2>
<ul>
  <li>High-volume routine operations — CABG, valve replacement, primary joint replacement, routine oncology surgery.</li>
  <li>Cases where surgeon volume dominates outcome — India's big surgical centers run 3–10× the case volume of most German academic hospitals in the same specialty.</li>
  <li>Cost-constrained cases with otherwise good options — if the patient can get a 90%-quality outcome at 15% of the cost, that's usually the better trade.</li>
  <li>Most pediatric cardiac, hepatobiliary, and solid-organ transplant cases — the highest-volume programs in India are on par with any in the world.</li>
</ul>

<h2>When Germany is worth the price tag</h2>
<ul>
  <li>Rare-tumor oncology — molecular medicine, protonbeam, clinical-trial access. The ecosystem advantage is real.</li>
  <li>Complex revision surgery — a second or third time on a joint, a bypass after a failed bypass, a spine reoperation.</li>
  <li>Neurosurgery for rare pathology — Germany's neurosurgical depth on AVMs, awake craniotomies, and complex skull base is very hard to match.</li>
  <li>Cases where your insurance will actually cover Germany but not India — for some European and Gulf policies, this is decisive.</li>
  <li>Cases where the patient or family strongly prefers English-native or German-speaking care teams — cultural fit matters more than price at that point.</li>
</ul>

<h2>The pattern inside both markets</h2>
<p>Within India, the variance between a tier-1 center (Medanta, Apollo, Fortis flagship, Max Saket, Manipal) and a smaller regional hospital is enormous. Within Germany, the variance between an academic medical center (Charité, Heidelberg, LMU) and a smaller private clinic is also real. Country choice gets you into the right rough range; center and surgeon choice within the country determines the outcome.</p>

<h2>The honest trade-off</h2>
<p>You're not paying 8× for 8× better outcomes. You're paying 8× for: access to rare-disease expertise, stronger multidisciplinary infrastructure, native-language communication, and the psychological comfort of being in a higher-trust regulatory environment. For cases where those things matter, the cost is defensible. For cases where they don't, paying for them is money on the table.</p>

<p>If you're comparing a specific case, send us the proposed treatment plan — we'll tell you honestly which side of this line we think it falls on.</p>
    `.trim(),
  },
];

async function main() {
  const sql = postgres(process.env.DATABASE_URL!, { max: 1, prepare: false });
  let n = 0;
  for (const p of POSTS) {
    const metaDesc = p.excerpt.length <= 160 ? p.excerpt : p.excerpt.slice(0, 157) + "...";
    await sql.unsafe(
      `
      INSERT INTO blog_posts (
        slug, title, excerpt, content, category, author_name,
        status, published_at, meta_title, meta_description, created_at, updated_at
      ) VALUES ($1, $2, $3, $4, $5, $6, 'published', $7, $8, $9, NOW(), NOW())
      ON CONFLICT (slug) DO UPDATE SET
        title = EXCLUDED.title,
        excerpt = EXCLUDED.excerpt,
        content = EXCLUDED.content,
        category = EXCLUDED.category,
        author_name = EXCLUDED.author_name,
        meta_title = EXCLUDED.meta_title,
        meta_description = EXCLUDED.meta_description,
        published_at = EXCLUDED.published_at,
        updated_at = NOW()
    `,
      [
        p.slug,
        p.title,
        p.excerpt,
        p.content,
        p.category,
        p.authorName,
        p.publishedAt,
        p.title.length <= 65 ? p.title : p.title.slice(0, 62) + "...",
        metaDesc,
      ],
    );
    n++;
  }
  console.log(`upserted ${n} blog posts`);
  await sql.end();
}

main().catch((e) => {
  console.error(e);
  process.exit(1);
});
